Wissenschaftliche Artikel der BAM
Filtern
Dokumenttyp
- Zeitschriftenartikel (34)
- Sonstiges (6)
Schlagworte
- Affinity chromatography (6)
- ELISA (5)
- IgG (5)
- Biosensor (4)
- Fluorescence (4)
- HPLC (4)
- Immunoassay (4)
- Immunosensor (4)
- Lab-on-a-chip (4)
- Mass spectrometry (4)
- Nitrotyrosine (4)
- Protein A (4)
- Reference material (4)
- Reproducibility (4)
- Traceability (4)
- Allergy (3)
- Antibodies (3)
- Diagnostics (3)
- FPLC (3)
- Hybridoma (3)
- Immunocapture (3)
- Immunoglobulins (3)
- Monoclonal antibody (3)
- Nitration (3)
- Protein G (3)
- Quality Control (3)
- Tyrosine (3)
- Affinity Chromatography (2)
- Affinitätschromatographie (2)
- Air pollution (2)
- Antibody coating (2)
- Aromatic amino acid analysis (2)
- Biochip (2)
- Chromatography (2)
- Copper (2)
- Dityrosine (2)
- Documentation (2)
- HTS (2)
- Immunoaffinity extraction (2)
- Immunoprecipitation (2)
- MALDI (2)
- Magnetic resonance imaging (2)
- Metrology (2)
- Microarray (2)
- Monoclonal Antibodies (2)
- Monolithic column (2)
- Nanoparticles (2)
- Nickel (2)
- Nitrogen oxides (2)
- Open Science (2)
- Peptide (2)
- Peptide library (2)
- Phenylalanine (2)
- Protein nitration (2)
- Proximity-enhanced reaction (2)
- Purification (2)
- Quality control (2)
- Regeneration (2)
- Sapphire (2)
- Screening (2)
- Sequence coverage (2)
- Synthetic peptides (2)
- 150th anniversary (1)
- 150th anniversary of BAM (1)
- 2,5-dihydroxyacetophenone (1)
- 280 nm (1)
- 6xHis (1)
- AAA (1)
- AAAA (1)
- ABC (1)
- ABID (1)
- ATCUN (1)
- Aautomatisation (1)
- Acute myocardial infarction (1)
- Additive Fertigung (1)
- Additive Manufacturing (1)
- Affinity (1)
- Affinity Extraction (1)
- Affinity Separation (1)
- Affinity extraction (1)
- Affinitätsextraktion (1)
- Agarose (1)
- Air filter samples (1)
- Air particulate matter (1)
- Airport (1)
- Alanine scan (1)
- Aluminum oxide (1)
- Amino acid analysis (1)
- Amplification (1)
- Analysis (1)
- Analytical sciences (1)
- Anthropocene (1)
- Antibody Purification (1)
- Antibody identification (1)
- Antibody-gated indicator delivery (1)
- Antikörper (1)
- Array (1)
- Atmospheric aerosol (1)
- Augenbohne (1)
- Automated Purification (1)
- Aviation (1)
- BAM (1)
- BCA test (1)
- Back-side integration (1)
- Bacterial lysates (1)
- Benchmarking study (1)
- Benzene-1,3,5-tricarboxylic acid (1)
- Bet v 1 (1)
- Betula pendula (1)
- Binder (1)
- Binding molecule (1)
- Bioanalysis (1)
- Biochemistry (1)
- Bioconjugation (1)
- Bioinformatics (1)
- Biomarker (1)
- Biosensing (1)
- Biosensors (1)
- Bioseparation (1)
- Biotechnology (1)
- Birch pollen allergen (1)
- Bombs (1)
- Border surveillance (1)
- Borosilicate Glass (1)
- Borosilicatglas (1)
- Borosilikatglas (1)
- Bovine serum albumin (BSA) (1)
- Bradford (1)
- Bundesanstalt für Materialforschung und -prüfung (1)
- Byproducts (1)
- COVID-19 (1)
- Calibration (1)
- Cardiac troponin (1)
- Cardiovascular (1)
- Carrier (1)
- Carrier protein (1)
- Carrier-Material (1)
- Chelate (1)
- Chemical evolution (1)
- Chemical protein modification (1)
- Chemiluminescence (1)
- Chicken antibodies (1)
- Chirality (1)
- Citation (1)
- Citizen Science (1)
- Cleavage (1)
- Click chemistry (1)
- Clones (1)
- Cmos (1)
- Collection (1)
- Column holder (1)
- Combinatorial chemistry (1)
- Combinatorial peptide library (1)
- Combustion (1)
- Commercialization (1)
- Compartmentalization (1)
- Competitive Immunoassay (1)
- Compound-independent calibration (1)
- Concentration step (1)
- Confiscation (1)
- Conformation (1)
- Construction (1)
- Continuous Sensor (1)
- Contrast agent (1)
- Corona virus (1)
- Corundum (1)
- Crosslinker (1)
- Customs (1)
- Cytoplasm (1)
- DHAP (1)
- Damage-associated molecular patterns (DAMPs) (1)
- De novo peptide sequencing (1)
- Deep learning-based tools (1)
- Degradation (1)
- Dendrimer (1)
- Derivatization (1)
- Detection (1)
- Diagnosis (1)
- Diagnostic Antibodies (1)
- Diesel exhaust (1)
- Digital immunoassay (1)
- Dimerization (1)
- Dityrosine crosslinking (1)
- Docking (1)
- Down Stream Processing (1)
- Downstream Processing (1)
- Downstream processing (1)
- Druckstabilität (1)
- Drug search (1)
- Drug trafficking (1)
- EDTAD (1)
- Editorial (1)
- Elastin-specific contrast agent ESMA (1)
- Element Specific Bioimaging Using Laser Ablation (1)
- Emergency (1)
- Enantiomeric excess ee (1)
- Encapsulation (1)
- Enhancement (1)
- Environment (1)
- Environmental pollutants (1)
- Error correction (1)
- Escherichia coli (1)
- Ethylenediaminetetraacetic acid (1)
- Etofenprox (1)
- Evanescent wave (1)
- Exhaust (1)
- Experiment (1)
- Explosiven (1)
- Explosives detection (1)
- False Positives (1)
- Flow injection immunoassay (1)
- Fluorescence label (1)
- Folding chirality (1)
- Gadofosveset (1)
- Gadolinium-based contrast agent (1)
- Gadovist (1)
- Gated materials (1)
- Gesteuerten Nanopartikeln (1)
- Github (1)
- Glasmonolith (1)
- Glass (1)
- Glass Support (1)
- Grass pollen (1)
- Hapten Immunoassay (1)
- Hay fever (1)
- Heart attack (1)
- Heavy chains (1)
- Herceptin (1)
- HexaHis-Tag (1)
- High pH (1)
- High-Speed (1)
- High-Speed Separations (1)
- High-throughput (1)
- Highspeed (1)
- His6 (1)
- His8 (1)
- Histidine (1)
- Human Plasma (1)
- Hydrochloric acid (1)
- Hydrolysis (1)
- IMAC purification (1)
- Identity (1)
- IgE (1)
- IgG determination (1)
- IgY (1)
- Illicit drug (1)
- Immobilisierung (1)
- Immunglobulin (1)
- Immunglobuline (1)
- Immunoassays (1)
- Immunoglobulin E (1)
- Immunometric assay (1)
- Immunometric biosensor (1)
- Impact (1)
- Impurites (1)
- Inductively Coupled Mass Spectroscopy (1)
- Inflammation (1)
- Inhibition (1)
- Internal standard (1)
- International drug trade (1)
- Jahrestag (1)
- Kjeldahl (1)
- LC-UV absorbance (1)
- LIF (1)
- Lab on a chip (1)
- Lab-on-a-Chip (1)
- Label (1)
- Ladder sequencing (1)
- Laser-induced fluorescence (1)
- Lateral flow assay (1)
- Library (1)
- Life sciences (1)
- Light chain (1)
- Light chains (1)
- Limit of detection (1)
- Low-cost (1)
- Luminol (1)
- MALDI-TOF MS (1)
- MR Angiography (1)
- MST (1)
- Material sciences (1)
- Mesoporous particles (1)
- Metalloprotein (1)
- Method (1)
- Microfluidic mixing (1)
- Microfluidic system (1)
- Microfluidics (1)
- Micrometeorites (1)
- Miller and Urey (1)
- Miniaturization (1)
- Missing fragmentation sites (1)
- Mobile phase (1)
- Molecular-MRI (1)
- Monoclonal Antibody (1)
- Monoclonal antibodies (1)
- Monolith (1)
- Multiplex (1)
- Multiplexing (1)
- Murchison meteorite (1)
- NIST (1)
- NIST-mAb 8671 (1)
- Nanocarrier (1)
- Nanoparticle (1)
- Nanoscience (1)
- Narcotics (1)
- Neoallergen (1)
- Neoepitopes (1)
- Nickel chelate (1)
- Nonspecific binding (NSB) (1)
- Nucleocapsid (1)
- OBOC library (1)
- Oligomerization (1)
- On-chip screening (1)
- One-bead-one-compound library (1)
- Online biosensor (1)
- Online detection (1)
- Open science (1)
- Optical detection (1)
- Orbitrap (1)
- Oriented immobilization (1)
- Ozone (1)
- PIC technology (1)
- Pattern recognition receptor (1)
- Peer review (1)
- Peptide aptamers (1)
- Peptide binder (1)
- Peptide folding (1)
- Peptide mass fingerprinting (1)
- Peptides (1)
- Permethrin (1)
- Peroxidase (1)
- Pflanzenvirus (1)
- Pharmaceutical (1)
- Phenothrin (1)
- Phenylketonuria (1)
- Phl p 5 (1)
- Phleum pratense (1)
- Photonic biosensor (1)
- Plant virus (1)
- Plasma (1)
- Polishing (1)
- Pollen extract (1)
- Pollutant (1)
- Polyclonal Antibodies (1)
- Polyglycerol (1)
- Porous rock (1)
- Prebiotic chemistry (1)
- Preprocessing (1)
- Primordial soup (1)
- Protein (1)
- Protein Purification (1)
- Protein content (1)
- Protein degradation (1)
- Protein folding (1)
- Protein hydrolysis (1)
- Protein oligomerization (1)
- Protein oligomers (1)
- Protein quantification (1)
- Protein test (1)
- Proteinoid (1)
- Purity (1)
- Quality assurance (1)
- Quantitative protein analysis (1)
- RBD (1)
- Racemate (1)
- Recombinant Antibody (1)
- Recombinant antibody (1)
- Recombinant protein (1)
- Reference materials (1)
- References (1)
- Reinigung (1)
- Replication (1)
- Replication crisis (1)
- Reproducibility crisis (1)
- Resonance wavelength shift (1)
- Ring resonator (1)
- Robustness (1)
- SBA-15 (1)
- SBA-16 (1)
- SPR (1)
- Schlangenbohne (1)
- Scientific publication (1)
- Security (1)
- Segregation (1)
- Self-assembled monolayers (SAM) (1)
- Self-assembly (1)
- Sensor (1)
- Separation (1)
- Sequencing (1)
- Sequencing algorithm (1)
- Serum (1)
- Silanization (1)
- Single molecule (1)
- Sintered Material (1)
- Software (1)
- Solid support (1)
- Solid-phase extraction (SPE) (1)
- Special issue (1)
- Spike protein (1)
- Stabilization (1)
- Stationäre Phase (1)
- Surface derivatization (1)
- Surface plasmon resonance (1)
- Surrogate citations (1)
- TLR4 activation (1)
- Target (1)
- Terephthalic acid (1)
- Terrorism (1)
- Therapeutic Antibodies (1)
- Tholins (1)
- Titan-Halterung (1)
- Toll-like receptor 4 (1)
- Topical collection: Analytical Methods and Applications in the Materials and Life Sciences (1)
- Trastuzumab (1)
- Trennung (1)
- Trust (1)
- Tryptic digest (1)
- Tryptophan (1)
- Type-I pyrethroids (1)
- Ultrasensitive (1)
- Upscaling (1)
- Validation (1)
- Vigna unguiculata (1)
- Visualization (1)
- Wipe test (1)
- Zenodo (1)
- biokompatibel (1)
- gesintert (1)
- self-replication (1)
Organisationseinheit der BAM
- 1 Analytische Chemie; Referenzmaterialien (40) (entfernen)
Thousands of antibodies for diagnostic and other analytical purposes are on the market. However, it is often difficult to identify duplicates, reagent changes, and to assign the correct original publications to an antibody. This slows down scientific progress and might even be a cause of irreproducible research and a waste of resources. Recently, activities were started to suggest the sole use of recombinant antibodies in combination with the open communication of their sequence. In this case, such uncertainties should be eliminated. Unfortunately, this approach seems to be rather a long-term vision since the development and manufacturing of recombinant antibodies remain quite expensive in the foreseeable future. Nearly all commercial antibody suppliers also may be reluctant to publish the sequence of their antibodies, since they fear counterfeiting. De novo sequencing of antibodies is also not feasible today for a reagent user without access to the hybridoma clone. Nevertheless, it seems to be crucial for any scientist to have the opportunity to identify an antibody undoubtedly to guarantee the traceability of any research activity using antibodies from a third party as a tool. For this purpose, we developed a method for the identification of antibodies based on a MALDI-TOF MS fingerprint. To circumvent lengthy denaturation, reduction, alkylation, and enzymatic digestion steps, the fragmentation was performed with a simple formic acid hydrolysis step. Eighty-nine unknown monoclonal antibodies were used for this study to examine the feasibility of this approach. Although the molecular assignment of peaks was rarely possible, antibodies could be easily recognized in a blinded test, simply from their mass-spectral fingerprint. A general protocol is given, which could be used without any optimization to generate fingerprints for a database. We want to propose that, in most scientific projects relying critically on antibody reagents, such a fingerprint should be established to prove and document the identity of the used antibodies, as well as to assign a specific reagent to a datasheet of a commercial supplier, public database record, or antibody ID.
The primary screening of hybridoma cells is a time-critical and laborious step during the development of monoclonal antibodies. Often, critical errors occur in this phase, which supports the notion that the generation of monoclonal antibodies with hybridoma technology is difficult to control and hence, a risky venture. We think that it is crucial to improve the screening process to eliminate most of the critical deficits of the conventional approach. With this new microarray-based procedure, several advances could be achieved: Selectivity for excellent binders, high-throughput, reproducible signals, avoidance of misleading avidity (multivalency) effects, and performance of simultaneous competition experiments. The latter can also be used to select clones of desired cross-reactivity properties. In this paper, a model system with two excellent clones against carbamazepine, two weak clones, and blank supernatant containing fetal bovine serum was designed to examine the effectiveness of the new system. The excellent clones could be detected largely independent of the immunoglobulin G (IgG) concentration, which is usually unknown during the clone screening since the determination and subsequent adjustment of the antibody concentration are not feasible in most cases. Furthermore, in this approach, the enrichment, isolation, and purification of IgG for characterization is not necessary. Raw cell culture supernatant can be used directly, even when fetal calf serum (FCS) or other complex media is used. In addition, an improved method for the oriented antibody-immobilization on epoxy-silanized slides is presented. Based on the results of this model system with simulated hybridoma supernatants, we conclude that this approach should be preferable to most other protocols leading to many false positives, causing expensive and lengthy elimination steps to weed out the poor clones.
Preactivation crosslinking – An efficient method for the oriented immobilization of antibodies
(2019)
Crosslinking of proteins for their irreversible immobilization on surfaces is a proven and popular method. However, many protocols lead to random orientation and the formation of undefined or even inactive by-products. Most concepts to obtain a more targeted conjugation or immobilization requires the recombinant modification of at least one binding partner, which is often impractical or prohibitively expensive. Here a novel method is presented, which is based on the chemical preactivation of Protein A or G with selected conventional crosslinkers. In a second step, the antibody is added, which is subsequently crosslinked in the Fc part. This leads to an oriented and covalent immobilization of the immunoglobulin with a very high yield. Protocols for Protein A and Protein G with murine and human IgG are presented. This method may be useful for the preparation of columns for affinity chromatography, immunoprecipitation, antibodies conjugated to magnetic particles, permanent and oriented immobilization of antibodies in biosensor systems, microarrays, microtitration plates or any other system, where the loss of antibodies needs to be avoided, and maximum binding capacity is desired. This method is directly applicable even to antibodies in crude cell culture supernatants, raw sera or protein-stabilized antibody preparations without any purification nor enrichment of the IgG. This new method delivered much higher signals as a traditional method and, hence, seems to be preferable in many applications.
Preactivation Crosslinking - An Efficient Method for the Oriented Immobilization of Antibodies
(2019)
Crosslinking of proteins for their irreversible immobilization on surfaces is a proven and popular method. However, many protocols lead to random orientation and the formation of undefined or even inactive by-products. Most concepts to obtain a more targeted conjugation or immobilization requires the recombinant modification of at least one binding partner, which is often impractical or prohibitively expensive. Here a novel method is presented, which is based on the chemical preactivation of Protein A or G with selected conventional crosslinkers. In a second step, the antibody is added, which is subsequently crosslinked in the Fc part. This leads to an oriented and covalent immobilization of the immunoglobulin with a very high yield. Protocols for Protein A and Protein G with murine and human IgG are presented. This method may be useful for the preparation of columns for affinity chromatography, immunoprecipitation, antibodies conjugated to magnetic particles, permanent and oriented immobilization of antibodies in biosensor systems, microarrays, microtitration plates or any other system, where the loss of antibodies needs to be avoided, and maximum binding capacity is desired. This method is directly applicable even to antibodies in crude cell culture supernatants, raw sera or protein-stabilized antibody preparations without any purification nor enrichment of the IgG. This new method delivered much higher signals as a traditional method and, hence, seems to be preferable in many applications.
Screening of one-bead-one-compound (OBOC) libraries is a proven procedure for the identification of protein-binding ligands. The demand for binders with high affinity and specificity towards various targets has surged in the biomedical and pharmaceutical field in recent years. The traditional peptide screening involves tedious steps such as affinity selection, bead picking, sequencing, and characterization. Herein, we present a high-throughput “all-on-one chip” system to avoid slow and technically complex bead picking steps. On a traditional glass slide provided with an electrically conductive tape, beads of a combinatorial peptide library are aligned and immobilized by application of a precision sieve. Subsequently, the chip is incubated with a fluorophore-labeled target protein. In a fluorescence scan followed by matrix-assisted laser desorption/ionization (MALDI)-time of flight (TOF) mass spectrometry, high-affinity binders are directly and unambiguously sequenced with high accuracy without picking of the positive beads. The use of an optimized ladder sequencing approach improved the accuracy of the de-novo sequencing step to nearly 100%. The new technique was validated by employing a FLAG-based model system, identifying new peptide binders for the monoclonal M2 anti-FLAG antibody, and was finally utilized to search for IgG-binding peptides. In the present format, more than 30,000 beads can be screened on one slide.
Therapeutische Antikörper sind innerhalb weniger Jahre zur wichtigsten pharmazeutischen Produktklasse aufgestiegen. Für 2023 werden weltweite Umsätze von über 200 Milliarden USD erwartet. Auch diagnostische Antikörper sind mittlerweile unverzichtbare Produkte, auf deren Basis zahllose Immunoassays und andere Schnelltests entwickelt wurden. Neben der bereits sehr aufwendigen Herstellung von Antikörpern ist deren Aufreinigung aus komplexen Zellkulturmedien oder Blutseren und -plasmen zu einem Engpass in der Produktion und Nutzung dieser komplexen Proteine geworden. Schnelle und einfache Reinigungsmethoden für Antikörper sind daher sehr gefragt.
Hepcidin-25 was identified as the main iron regulator in the human body, and it by binds to the sole iron-exporter ferroportin. Studies showed that the N-terminus of hepcidin is responsible for this interaction, the same N-terminus that encompasses a small copper(II)-binding site known as the ATCUN (amino-terminal Cu(II)- and Ni(II)-binding) motif. Interestingly, this copper-binding property is largely ignored in most papers dealing with hepcidin-25. In this context, detailed investigations of the complex formed between hepcidin-25 and copper could reveal insight into its biological role. The present work focuses on metal-bound hepcidin-25 that can be considered the biologically active form. The first part is devoted to the reversed-phase chromatographic separation of copper-bound and copper-free hepcidin-25 achieved by applying basic mobile phases containing 0.1% ammonia. Further, mass spectrometry (tandem mass spectrometry (MS/MS), high-resolution mass spectrometry HRMS)) and nuclear magnetic resonance (NMR) spectroscopy were employed to characterize the copper-peptide. Lastly, a three-dimensional (3D)model of hepcidin-25with bound copper(II) is presented. The identification of metal complexes and potential isoforms and isomers, from which the latter usually are left undetected by mass spectrometry, led to the conclusion that complementary analytical methods are needed to characterize a peptide calibrant or reference material comprehensively. Quantitative nuclear magnetic resonance (qNMR), inductively-coupled plasma mass spectrometry (ICP-MS), ion-mobility spectrometry (IMS) and chiral amino acid analysis (AAA) should be considered among others.
Online immunocapture ICP‑MS for the determination of the metalloprotein ceruloplasmin in human serum
(2018)
The human copper-protein ceruloplasmin (Cp) is the major copper-containing protein in the human body. The accurate determination of Cp is mandatory for the reliable diagnosis of several diseases. However, the analysis of Cp has proven to be difficult. The aim of our work was a proof of concept for the determination of a metalloprotein-based on online immunocapture ICP-MS. The immuno-affinity step is responsible for the enrichment and isolation of the analyte from serum, whereas the compound-independent quantitation with ICP-MS delivers the sensitivity,
precision, and large dynamic range. Off-line ELISA (enzyme-linked immunosorbent assay) was used in parallel to confirm the elution profile of the analyte with a structure-selective method. The total protein elution was observed with the 32S mass trace. The ICP-MS signals were normalized on a 59Co signal. The human copper-protein Cp could be selectively determined. This was shown with pure Cp and with a sample of human serum. The good correlation with off-line ELISA shows that Cp could be captured and eluted selectively from the anti-Cp affinity column and subsequently determined by the copper signal of ICP-MS.
The quality of research antibodies is an issue for decades. Although several papers have been published to improve the situation, their impact seems to be limited. This publication makes the effort to simplify the description of validation criteria in a way that the occasional antibody user is able to assess the validation level of an immunochemical reagent. A simple, 1-page checklist is supplied for the practical application of these criteria.